These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 35373127)
1. Hepatorenal Syndrome Type 1: From Diagnosis Ascertainment to Goal-Oriented Pharmacologic Therapy. Velez JCQ Kidney360; 2022 Feb; 3(2):382-395. PubMed ID: 35373127 [TBL] [Abstract][Full Text] [Related]
2. AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review. Flamm SL; Wong F; Ahn J; Kamath PS Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2707-2716. PubMed ID: 36075500 [TBL] [Abstract][Full Text] [Related]
3. AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review. Garcia-Tsao G; Abraldes JG; Rich NE; Wong VW Gastroenterology; 2024 Jan; 166(1):202-210. PubMed ID: 37978969 [TBL] [Abstract][Full Text] [Related]
4. Hepatorenal Syndrome With Acute Kidney Injury: Diagnosis and Medical Management. Erstad BL Ann Pharmacother; 2024 Feb; 58(2):156-164. PubMed ID: 37271967 [TBL] [Abstract][Full Text] [Related]
5. Monitoring Renal Function and Therapy of Hepatorenal Syndrome Patients with Cirrhosis. Juanola A; Solé C; Toapanta D; Ginès P; Solà E Clin Liver Dis; 2021 May; 25(2):441-460. PubMed ID: 33838860 [TBL] [Abstract][Full Text] [Related]
6. Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis. Ma AT; Solé C; Juanola A; Escudé L; Napoleone L; Avitabile E; Pérez-Guasch M; Carol M; Pompili E; Gratacós-Ginés J; Soria A; Rubio AB; Cervera M; Moreta MJ; Morales-Ruiz M; Solà E; Poch E; Fabrellas N; Graupera I; Pose E; Ginès P J Hepatol; 2024 Sep; 81(3):441-450. PubMed ID: 38479614 [TBL] [Abstract][Full Text] [Related]
7. Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting. Nadim MK; Kellum JA; Forni L; Francoz C; Asrani SK; Ostermann M; Allegretti AS; Neyra JA; Olson JC; Piano S; VanWagner LB; Verna EC; Akcan-Arikan A; Angeli P; Belcher JM; Biggins SW; Deep A; Garcia-Tsao G; Genyk YS; Gines P; Kamath PS; Kane-Gill SL; Kaushik M; Lumlertgul N; Macedo E; Maiwall R; Marciano S; Pichler RH; Ronco C; Tandon P; Velez JQ; Mehta RL; Durand F J Hepatol; 2024 Jul; 81(1):163-183. PubMed ID: 38527522 [TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of terlipressin and norepinephrine for treatment of hepatorenal syndrome-acute kidney injury: A systematic review and meta-analysis. Olson JC; Subramanian RM PLoS One; 2024; 19(1):e0296690. PubMed ID: 38285703 [TBL] [Abstract][Full Text] [Related]
16. Acute Kidney Injury in Patients with Liver Disease. Cullaro G; Kanduri SR; Velez JCQ Clin J Am Soc Nephrol; 2022 Nov; 17(11):1674-1684. PubMed ID: 35902128 [TBL] [Abstract][Full Text] [Related]
17. The Current Management of Hepatorenal Syndrome-Acute Kidney Injury in the United States and the Potential of Terlipressin. Flamm SL; Brown K; Wadei HM; Brown RS; Kugelmas M; Samaniego-Picota M; Burra P; Poordad F; Saab S Liver Transpl; 2021 Aug; 27(8):1191-1202. PubMed ID: 33848394 [TBL] [Abstract][Full Text] [Related]
18. Hepatorenal syndrome in the era of acute kidney injury. Solé C; Pose E; Solà E; Ginès P Liver Int; 2018 Nov; 38(11):1891-1901. PubMed ID: 29845739 [TBL] [Abstract][Full Text] [Related]